Compounders had been allowed to produce and sell hundreds of thousands of their own versions of popular anti-obesity drugs, ...

India's drug price regulator has capped retail prices for 53 drug formulations used in treating various diseases and ...

Kidney transplant recipients with type 2 diabetes treated with a new class of anti-obesity drugs were less likely to experience organ failure and survived longer, a new study shows. Not only is ...

Sotagliflozin, a newly FDA-approved medication for treating type 2 diabetes and kidney disease with added cardiovascular risks, has been shown to greatly lower the risk of heart attacks and ...

A new study reveals that anti-obesity drugs can help kidney transplant recipients with type 2 diabetes reduce the risk of organ failure and increase survival rates. Researchers found that GLP-1 ...

A federal judge ended compounding pharmacies’ ability to make copies of the weight loss and diabetes drugs Zepbound and ...

It also fixed the price of a popular drug combination used to treat type 2 diabetes mellitus—dapagliflozin, teneligliptin, and metformin—at ₹11.60 per tablet, and the price of another anti ...

Background: Some anti-diabetic drugs have been proved to be a tumor suppressor or activator. The associations of three relatively new classes of anti-diabetic medications–glucagon-like peptide-1 ...

and drug stability of current therapies remain limited. Plant-based treatments, which have long been used in traditional medicine, are now being investigated for anti-diabetic properties.

Kidney transplant recipients with type 2 diabetes treated with a new class of anti-obesity drugs were less likely to experience organ failure and survived longer, a new study shows. Not only is ...

A federal judge has effectively ended the ability of compounding pharmacies to make their own copies of Eli Lilly’s weight loss and diabetes ... of popular anti-obesity drugs, so long as the ...

In this review, we summarize the function of certain anti-diabetic medications with known thermogenic mechanisms and focus on various receptor signaling pathways, such as previously well-known and ...